Biochemical analysis of a missense mutation in aceruloplasminemia
- PMID: 11689569
- DOI: 10.1074/jbc.M109123200
Biochemical analysis of a missense mutation in aceruloplasminemia
Abstract
Aceruloplasminemia is an inherited neurodegenerative disease characterized by parenchymal iron accumulation secondary to loss-of-function mutations in the ceruloplasmin gene. To elucidate the molecular pathogenesis of aceruloplasminemia, the biosynthesis of a missense mutant ceruloplasmin (P177R) occurring in an affected patient was examined. Chinese hamster ovary cells transfected with cDNAs encoding secreted and glycosylphosphatidylinositol (GPI)-linked wild-type or P177R human ceruloplasmin were examined by pulse-chase metabolic labeling. These experiments, as well as immunofluorescent analysis and N-linked glycosylation studies, indicate that both the secreted and GPI-linked forms of the P177R mutant are retained in the endoplasmic reticulum (ER). The P177R mutation resides within a novel motif, which is repeated six times in human ceruloplasmin and is conserved in the homologous proteins hephaestin and factor VIII. Analysis of additional mutations in these motifs suggests a critical role for this region in ceruloplasmin trafficking and indicates that substitution of the arginine residue is critical to the ER retention of the P177R mutant. Metabolic labeling of transfected Chinese hamster ovary cells with (64)Cu indicates that the P177R mutant is retained in the ER as an apoprotein and that copper is incorporated into both secreted and GPI-linked ceruloplasmin as a late event in the secretory pathway. Taken together, these studies reveal new insights into the determinants of holoceruloplasmin biosynthesis and indicate that aceruloplasminemia can result from retention of mutant ceruloplasmin within the early secretory pathway.
Similar articles
-
Molecular and pathological basis of aceruloplasminemia.Biol Res. 2006;39(1):15-23. doi: 10.4067/s0716-97602006000100003. Biol Res. 2006. PMID: 16629161
-
Biochemical features of ceruloplasmin gene mutations linked to aceruloplasminemia.Neuromolecular Med. 2006;8(3):361-74. doi: 10.1385/NMM:8:3:361. Neuromolecular Med. 2006. PMID: 16775387
-
Mechanisms of copper incorporation into human ceruloplasmin.J Biol Chem. 2002 Nov 29;277(48):46632-8. doi: 10.1074/jbc.M206246200. Epub 2002 Sep 25. J Biol Chem. 2002. PMID: 12351628
-
Aceruloplasminemia: an inherited neurodegenerative disease with impairment of iron homeostasis.Am J Clin Nutr. 1998 May;67(5 Suppl):972S-977S. doi: 10.1093/ajcn/67.5.972S. Am J Clin Nutr. 1998. PMID: 9587138 Review.
-
Aceruloplasminemia: an update.Int Rev Neurobiol. 2013;110:125-51. doi: 10.1016/B978-0-12-410502-7.00007-7. Int Rev Neurobiol. 2013. PMID: 24209437 Review.
Cited by
-
Oxidative stress and major depression.J Clin Diagn Res. 2014 Dec;8(12):CC04-7. doi: 10.7860/JCDR/2014/10258.5292. Epub 2014 Dec 5. J Clin Diagn Res. 2014. PMID: 25653939 Free PMC article.
-
Iron chelation therapy in aceruloplasminaemia: study of a patient with a novel missense mutation.Gut. 2004 May;53(5):756-8. doi: 10.1136/gut.2003.030429. Gut. 2004. PMID: 15082597 Free PMC article.
-
Trace Elements Levels in Major Depressive Disorder-Evaluation of Potential Threats and Possible Therapeutic Approaches.Int J Mol Sci. 2023 Oct 11;24(20):15071. doi: 10.3390/ijms242015071. Int J Mol Sci. 2023. PMID: 37894749 Free PMC article. Review.
-
Ceruloplasmin regulates iron levels in the CNS and prevents free radical injury.J Neurosci. 2002 Aug 1;22(15):6578-86. doi: 10.1523/JNEUROSCI.22-15-06578.2002. J Neurosci. 2002. PMID: 12151537 Free PMC article.
-
Ceruloplasmin-ferroportin system of iron traffic in vertebrates.World J Biol Chem. 2014 May 26;5(2):204-15. doi: 10.4331/wjbc.v5.i2.204. World J Biol Chem. 2014. PMID: 24921009 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical